When.com Web Search

  1. Ad

    related to: drugs to reduce brain swelling

Search results

  1. Results From The WOW.Com Content Network
  2. Osmotherapy - Wikipedia

    en.wikipedia.org/wiki/Osmotherapy

    Cerebral Edema that resulted from brain tumor is represented by darker areas on this CT image. An increase in cerebral water content is called cerebral edema and it usually results from traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), intracerebral hemorrhage (ICH), subdural hematoma, ischemic stroke, brain tumors, infectious disorders and intracranial surgery.

  3. Cerebral edema - Wikipedia

    en.wikipedia.org/wiki/Cerebral_edema

    In general, cytotoxic edema is linked to cell death in the brain through excessive cellular swelling. [1] During cerebral ischemia for example, the blood–brain barrier remains intact but decreased blood flow and glucose supply leads to a disruption in cellular metabolism and creation of energy sources, such as adenosine triphosphate (ATP). [1]

  4. Arachidonate 5-lipoxygenase inhibitor - Wikipedia

    en.wikipedia.org/wiki/Arachidonate_5-lipoxygen...

    Examples of 5-LOX inhibitors include the pharmaceutical drugs ... Boswellia administration has been shown to reduce brain edema in patients irradiated for brain tumor ...

  5. GLP-1 drugs like Ozempic may protect brain health, several ...

    www.aol.com/glp-1-drugs-ozempic-may-170000610.html

    The study examines how GLP-1 medications reduce inflammation in the brain and how these drugs may be able to strengthen the blood-brain barrier. The use of the medications Wegovy, ...

  6. Anti-inflammatory - Wikipedia

    en.wikipedia.org/wiki/Anti-inflammatory

    Anti-inflammatory drugs, also called anti-inflammatories, make up about half of analgesics. These drugs remedy pain by reducing inflammation as opposed to opioids , which affect the central nervous system to block pain signaling to the brain.

  7. Anti-amyloid drugs - Wikipedia

    en.wikipedia.org/wiki/Anti-amyloid_drugs

    Aducanumab, sold under the brand name Aduhelm, is a monoclonal antibody designed to treat Alzheimer's disease. It is a monoclonal antibody that targets aggregated forms (plaque) of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup. [10] It was developed by Biogen and Eisai. [11] Aducanumab is given via intravenous infusion. [5] Aducanumab was ...

  8. New Research Offers Hope in the Fight Against Alzheimer’s - AOL

    www.aol.com/lifestyle/research-offers-hope-fight...

    Then the drug was linked to bleeding and swelling in the brain, symptoms not unlike those found in patients in the early aughts vaccine trial. Leqembi (lecanemab), which slows cognitive decline by ...

  9. Cerebroprotectant - Wikipedia

    en.wikipedia.org/wiki/Cerebroprotectant

    A cerebroprotectant (formerly known as a neuroprotectant) is a drug that is intended to protect the brain after the onset of acute ischemic stroke. [1] As stroke is the second largest cause of death worldwide and a leading cause of adult disability, over 150 drugs have been tested in clinical trials to provide cerebroprotection.